Americas Healthcare: Generic Pharmaceuticals: Initial take on tariff announcement

研报英文原文证据摘录

Americas Healthcare: Generic Pharmaceuticals: Initial take on tariff announcement

ect company or companies

referred to in this research report. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or

provide any assurance of returns to investors. Goldman Sachs (India) Securities Private Limited compliance officer and investor grievance contact

details, a copy of the annual compliance audit report and other relevant information and disclosures can be found at this link:

https://www.goldmansachs.com/worldwide/india/research-analyst. Japan: See below. Korea: This research, and any access to it, is intended only for

“professional investors” within the meaning of the Financial Services and Capital Markets Act, unless otherwise agreed by Goldman Sachs. Further

information on the subject company or companies referred to in this research may be obtained from Goldman Sachs (Asia) L.L.C., Seoul Branch. New

Zealand: Goldman Sachs New Zealand Limited and its affiliates are neither “registered banks” nor “deposit takers” (as defined in the Reserve Bank of

New Zealand Act 1989) in New Zealand. This research, and any access to it, is intended for “wholesale clients” (as defined in the Financial Advisers Act

2008) unless otherwise agreed by Goldman Sachs. A copy of certain Goldman Sachs Australia and New Zealand disclosure of interests is available at:

https://www.goldmansachs.com/disclosures/australia-new-zealand/index.html. Russia: Research reports distributed in the Russian Federation are not

advertising as defined in the Russian legislation, but are information and analysis not having product promotion as their main purpose and do not

provide appraisal within the meaning of the Russian legislation on appraisal activity.